Steward Partners Investment Advisory’s Celldex Therapeutics CLDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-400	Closed	-$15.9K	–	3588
2023 Q4	$15.9K	Hold	400	–	–	﹤0.01%	2513
2023 Q3	$11K	Hold	400	–	–	﹤0.01%	2559
2023 Q2	$13.6K	Buy	+400	New	+$13.6K	﹤0.01%	2468